Completed NA INTERVENTIONAL 1-arm NCT01361815

Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)

A Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI) for Subjects With MDD Who Complete/ Discontinued the CTP-0001-00 Protocol

Sponsor: Brainsway

Conditions Major Depressive Disorder, Recurrent, Unspecified Major Depressive Disorder, Single Episode, Unspecified

Interventions H-Coil Deep TMS in combination with SSRIs

Updated 9 times since 2017 Last updated: Jul 13, 2020 Started: Jul 31, 2011 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Major Depressive Disorder, Recurrent, Unspecified and Major Depressive Disorder, Single Episode, Unspecified, this trial is completed. The trial is conducted by Brainsway and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2020 — Jan 2021 [monthly]

Completed NA

Phase: PHASE3 → NA

▶ Show 4 earlier versions

Jun 2018 — Aug 2020 [monthly]

Completed PHASE3
Feb 2018 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — Feb 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brainsway

Data source: Brainsway

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Baltimore, United States , Belmont, United States , Be’er Ya‘aqov, Israel , Bonn, Germany , Charleston, United States , Dallas, United States , Davis, United States , Hod HaSharon, Israel , Jerusalem, Israel and 8 more locations